Although carcinoembryonic antigen (CEA) is currently the most commonly used serum tumor marker for CRC [6–9], it is not recommended as a screening or diagnostic tool for this neoplasm, especially in the early stages. This evidence concerns the gene CEACAM5 and colorectal carcinoma.